Asprosin is associated with anorexia and body fat mass in cancer patients
ConclusionsPatients with anorexia had significantly lower asprosin levels compared with patients without anorexia. We therefore speculated that asprosin might intervene in the development of cancer anorexia and serve as a potential therapeutic target.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Cholesterol | Eating Disorders & Weight Management | Gastric (Stomach) Cancer | Gastritis | Gastroenterology | Hormones | Lung Cancer | Nutrition | Study